Latest updates for Bayry
Fresh curated links around BAYRY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Bayer: Debt Remains A Problem, Value Remains Compelling
- TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
- Analyst Report: Roche Holding AG
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/4 days ago
Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum
seekingalpha.com
/1 month ago
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions
finance.yahoo.com
/1 week ago
Pfizer vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
pharmexec.com
/3 weeks ago
<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...
seekingalpha.com
/2 weeks ago
Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing
seekingalpha.com
/1 month ago
ImmunityBio: Intriguing Progress, If Not (Yet) Commercially - Still A Hold
investing.com
/3 weeks ago
BioMarin to acquire Alesta Therapeutics for up to $490 million
seekingalpha.com
/1 week ago
Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment
seekingalpha.com
/3 hours ago
Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1 '27
pharmexec.com
/1 week ago
<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>
fool.com
/2 weeks ago
Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing...
The company has increased its dividend for 30 consecutive years.
pharmexec.com
/1 week ago
<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...
pharmexec.com
/1 week ago
<![CDATA[Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion]]>
seekingalpha.com
/1 month ago
BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
BridgeBio: "Strong Buy" Attruby Differentiation And Several NDA Submissions In Play
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Bayry
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
investing.com
Recent coverage from public sources
Public source